846 related articles for article (PubMed ID: 12809998)
21. The incidence and risk factors of falls in Parkinson disease: prospective study.
Rudzińska M; Bukowczan S; Stożek J; Zajdel K; Mirek E; Chwała W; Wójcik-Pędziwiatr M; Banaszkiewicz K; Szczudlik A
Neurol Neurochir Pol; 2013; 47(5):431-7. PubMed ID: 24166564
[TBL] [Abstract][Full Text] [Related]
22. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
23. Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures.
Landers MR; Backlund A; Davenport J; Fortune J; Schuerman S; Altenburger P
J Neurol Phys Ther; 2008 Jun; 32(2):56-61. PubMed ID: 18645292
[TBL] [Abstract][Full Text] [Related]
24. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889
[TBL] [Abstract][Full Text] [Related]
25. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.
Amboni M; Stocchi F; Abbruzzese G; Morgante L; Onofrj M; Ruggieri S; Tinazzi M; Zappia M; Attar M; Colombo D; Simoni L; Ori A; Barone P; Antonini A;
Parkinsonism Relat Disord; 2015 Jun; 21(6):644-9. PubMed ID: 25899545
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
[TBL] [Abstract][Full Text] [Related]
28. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
LeWitt P; Oakes D; Cui L
Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
[TBL] [Abstract][Full Text] [Related]
29. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
30. Objective Gait and Balance Impairments Relate to Balance Confidence and Perceived Mobility in People With Parkinson Disease.
Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
Phys Ther; 2016 Nov; 96(11):1734-1743. PubMed ID: 27149959
[TBL] [Abstract][Full Text] [Related]
31. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
[TBL] [Abstract][Full Text] [Related]
32. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors.
Balash Y; Peretz C; Leibovich G; Herman T; Hausdorff JM; Giladi N
J Neurol; 2005 Nov; 252(11):1310-5. PubMed ID: 15895303
[TBL] [Abstract][Full Text] [Related]
33. Increased foot strike variability in Parkinson's disease patients with freezing of gait.
Shah J; Pillai L; Williams DK; Doerhoff SM; Larson-Prior L; Garcia-Rill E; Virmani T
Parkinsonism Relat Disord; 2018 Aug; 53():58-63. PubMed ID: 29773512
[TBL] [Abstract][Full Text] [Related]
34. Gait and upper limb variability in Parkinson's disease patients with and without freezing of gait.
Barbe MT; Amarell M; Snijders AH; Florin E; Quatuor EL; Schönau E; Fink GR; Bloem BR; Timmermann L
J Neurol; 2014 Feb; 261(2):330-42. PubMed ID: 24305993
[TBL] [Abstract][Full Text] [Related]
35. Impact of anticholinergic drugs withdrawal on motor function in patients with Parkinson's disease.
Saeedi Y; Ghadimi M; Rohani M; Emamikhah M; Shahidi G; Moghaddasi M; Habibi SAH
Clin Neurol Neurosurg; 2021 Mar; 202():106480. PubMed ID: 33503509
[TBL] [Abstract][Full Text] [Related]
36. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
Morris M; Iansek R; McGinley J; Matyas T; Huxham F
Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
[TBL] [Abstract][Full Text] [Related]
38. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
39. The Mini-BESTest is an independent predictor of falls in Parkinson Disease.
Lopes LKR; Scianni AA; Lima LO; de Carvalho Lana R; Rodrigues-De-Paula F
Braz J Phys Ther; 2020; 24(5):433-440. PubMed ID: 31377123
[TBL] [Abstract][Full Text] [Related]
40. Variability of Stepping during a Virtual Reality Paradigm in Parkinson's Disease Patients with and without Freezing of Gait.
Gilat M; Shine JM; Bolitho SJ; Matar E; Kamsma YP; Naismith SL; Lewis SJ
PLoS One; 2013; 8(6):e66718. PubMed ID: 23805270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
